+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Androgen Replacement Therapy Market - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027

  • PDF Icon

    Report

  • April 2020
  • Region: Global
  • Coherent Market Insights Pvt Ltd.
  • ID: 5327765
Androgen replacement therapy (ART), often referred to as testosterone replacement therapy (TRT), is a form of hormone therapy, in which androgens, often testosterone, are replaced. ART is often prescribed to counter the effects of male hypogonadism. It typically involves the administration of testosterone through injections, skin creams, patches, gels, or subcutaneous pellets. Testosterone replacement therapy is a promising technology for improving symptoms of hypogonadism and to raise the testosterone level. Furthermore, benefits related to application of testosterone replacement therapy include an increase in muscle tissue, overall surge in energy, and significant decrease in depression symptoms.

Market Dynamics

The androgen replacement therapy market is expected to witness growth during the forecast period owing to the increasing number of product launches in the market. For instance, in April 2019, Lupin announced the launch of Testosterone Gel, 1.62% (20.25 mg/1.25 g pump actuation) after receiving an approval from the U.S. Food and Drug Administration (FDA). The testosterone gel is the generic equivalent of AbbVie Inc’s AndroGel, 1.62%. It is indicated for replacement therapy in males for conditions associated with a deficiency or absence of endogenous testosterone primary hypogonadism (congenital or acquired) and hypogonadotropic hypogonadism.

However, the side effects caused due to androgen replacement therapy are expected to hamper the androgen replacement therapy market growth. The side effects from the androgen replacement therapy are chest pain, shortness of breath or trouble breathing, weakness in one part or one side of the body, slurred speech, sleep apnea, increased cholesterol levels, and increased blood pressure. For instance, in 2015, the U.S.FDA issued a warning about potential cardiovascular risks such as heart attack and stroke resulting from testosterone therapy.

Key features of the study:
  • This report provides in-depth analysis of the global androgen replacement rherapy market, market size (US$ Mn), and compound annual growth rate (CAGR (%)) for the forecast period: 2020-2027, considering 2019 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
  • It profiles key players in the global androgen replacement therapy market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key players covered as a part of this study are AbbVie, Inc., Allergan Plc, Bayer AG, Endo Pharmaceuticals, Inc., Eli Lilly and Company, Kyowa Kirin International Plc, Mylan N.V., Novartis International AG, Pfizer, Inc., Clarus Therapeutics, Ferring Holding SA, Perrigo Company Plc, Acerus Pharmaceuticals Corporation, Upsher-Smith Laboratories, LLC, Dr. Reddy's Laboratories, Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., and Par Pharmaceutical.
  • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
  • The global androgen replacement therapy market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for androgen replacement therapy market, research and consulting firms, new entrants, and financial analysts

Detailed Segmentation:

Global Androgen Replacement Therapy Market, By Product Type:
  • Creams/Gels
  • Patches
  • Injections
  • Implants
  • Orals Tablets/Capsules/Gums

Global Androgen Replacement Therapy Market, By Active Ingredient Type:
  • Testosterone
  • Methyl Testosterone
  • Testosterone Undecanoate
  • Testosterone Enanthate
  • Testosterone Cypionate

Global Androgen Replacement Therapy Market, By Distribution Channel:
  • Hospitals Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Global Androgen Replacement Therapy Treatment Market, By Region:
  • North America
  • By Country
  • U.S.
  • Canada
  • Latin America
  • By Country
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
  • By Country
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • By Country
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • By Country
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • By Country/Region
  • South Africa
  • Central Africa
  • North Africa

Company Profiles
  • AbbVie, Inc.*
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • Allergan Plc
  • Bayer AG
  • Endo Pharmaceuticals, Inc.
  • Eli Lilly and Company
  • Kyowa Kirin International Plc
  • Mylan N.V.
  • Novartis International AG
  • Pfizer, Inc.
  • Clarus Therapeutics
  • Ferring Holding SA
  • Perrigo Company Plc
  • Acerus Pharmaceuticals Corporation
  • Upsher-Smith Laboratories, LLC
  • Dr. Reddy's Laboratories
  • Bausch Health Companies Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Par Pharmaceutical

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions
  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Overview
  • Report Description
  • Market Definition and Scope
  • Executive Summary
  • Market Snippet, By Product Type
  • Market Snippet, By Active Ingredient Type
  • Market Snippet, By Distribution Channel
  • Market Snippet, By Region
  • Opportunity Map

3. Market Dynamics, Regulations, and Trends Analysis
  • Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
  • Impact Analysis
  • Market Trends
  • Regulatory Scenario
  • Reimbursement Scenario
  • New Product Launches/Approvals
  • Collaborations & Partnerships
  • Mergers & Acquisitions
  • PEST Analysis

4. Global Androgen Replacement Therapy Market, By Product Type, 2016 - 2027, (US$ Million)
  • Introduction
  • Market Share Analysis, 2019 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017 - 2027
  • Segment Trends
  • Creams/Gels
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Patches
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Injections
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Implants
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Oral Tablets/Capsules/Gums
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)

5. Global Androgen Replacement Therapy Market, By Active Ingredient Type, 2016 - 2027, (US$ Million)
  • Introduction
  • Market Share Analysis, 2019 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017 - 2027
  • Segment Trends
  • Testosterone
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Methyl Testosterone
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Testosterone Undecanoate
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Testosterone Enanthate
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Testosterone Cypionate
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)

6. Global Androgen Replacement Therapy Market, By Distribution Channel, 2016 - 2027, (US$ Million)
  • Introduction
  • Market Share Analysis, 2019 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017 - 2027
  • Segment Trends
  • Hospitals Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Retail Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Online Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)

7. Global Androgen Replacement Therapy Market, By Region, 2016 - 2027, (US$ Million)
  • Introduction
  • Market Share Analysis, By Region, 2018 and 2026 (%)
  • Y-o-Y Growth Analysis, By Region, 2017 - 2026
  • Regional Trends
  • North America
  • Market Size and Forecast, By Product Type, 2016 - 2027, (US$ Million)
  • Market Size and Forecast, By Active Ingredient Type, 2016 - 2027, (US$ Million)
  • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Million)
  • Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
  • U.S.
  • Canada
  • Europe
  • Market Size and Forecast, By Product Type, 2016 - 2027, (US$ Million)
  • Market Size and Forecast, By Active Ingredient Type, 2016 - 2027, (US$ Million)
  • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Million)
  • Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • Market Size and Forecast, By Product Type, 2016 - 2027, (US$ Million)
  • Market Size and Forecast, By Active Ingredient Type, 2016 - 2027, (US$ Million)
  • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Million)
  • Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
  • China
  • Japan
  • India
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
  • Market Size and Forecast, By Product Type, 2016 - 2027, (US$ Million)
  • Market Size and Forecast, By Active Ingredient Type, 2016 - 2027, (US$ Million)
  • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Million)
  • Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Africa
  • Market Size and Forecast, By Product Type, 2016 - 2027, (US$ Million)
  • Market Size and Forecast, By Active Ingredient Type, 2016 - 2027, (US$ Million)
  • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Million)
  • Market Size and Forecast, By Country/Region, 2016 - 2027, (US$ Million)
  • North Africa
  • Central Africa
  • South Africa
  • Middle East
  • Market Size and Forecast, By Product Type, 2016 - 2027, (US$ Million)
  • Market Size and Forecast, By Active Ingredient Type, 2016 - 2027, (US$ Million)
  • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Million)
  • Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
  • GCC Countries
  • Israel
  • Rest of Middle East

8. Competitive Landscape
  • Company Profiles
  • AbbVie, Inc.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • Allergan Plc
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • Bayer AG
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • Endo Pharmaceuticals, Inc.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • Eli Lilly and Company
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • Kyowa Kirin International Plc
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • Mylan N.V.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • Novartis International AG
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • Pfizer, Inc.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • Clarus Therapeutics
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • Ferring Holding SA
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • Perrigo Company Plc
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • Acerus Pharmaceuticals Corporation
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • Upsher-Smith Laboratories, LLC
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • Dr. Reddy's Laboratories
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • Bausch Health Companies Inc.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • Sun Pharmaceutical Industries Ltd.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • Par Pharmaceutical
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies

9. Section
  • References
  • Research Methodology
  • About Us and Sales Contact

Companies Mentioned

A selection of companies mentioned in this report includes:

  • AbbVie, Inc.
  • Allergan Plc
  • Bayer AG
  • Endo Pharmaceuticals, Inc.
  • Eli Lilly and Company
  • Kyowa Kirin International Plc
  • Mylan N.V.
  • Novartis International AG
  • Pfizer, Inc.
  • Clarus Therapeutics
  • Ferring Holding SA
  • Perrigo Company Plc
  • Acerus Pharmaceuticals Corporation
  • Upsher-Smith Laboratories, LLC
  • Dr. Reddy's Laboratories
  • Bausch Health Companies Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Par Pharmaceutical